Quality Assurance Investigations and Impurity Characterization during Upscaling of [¹⁷⁷Lu]Lu-PSMA^I&T

[¹⁷⁷Lu]Lu-PSMA^I&T is widely used for the radioligand therapy of metastatic castration-resistant prostate cancer (mCRPC). Since this kind of therapy has gained a large momentum in recent years, an upscaled production process yielding multiple patient doses in one batch has been...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Stefan Schmitl, Julia Raitanen, Stephan Witoszynskyj, Eva-Maria Patronas, Lukas Nics, Marius Ozenil, Victoria Weissenböck, Thomas L. Mindt, Marcus Hacker, Wolfgang Wadsak, Marie R. Brandt, Markus Mitterhauser
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	MDPI AG 2023-11-01
Σειρά:	Molecules
Θέματα:	[<sup>177</sup>Lu]Lu-PSMA<sup>-I&T</sup> radiolysis radioligand therapy upscaling quality assurance HPLC
Διαθέσιμο Online:	https://www.mdpi.com/1420-3049/28/23/7696
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!